Source: Annual Congress 2003 - Cystic fibrosis: basic science to clinical context



Rating:

Share or cite this content

Citations should be made in the following way:
F. A. Mata, J. De Gracia, A. Alvarez, D. de la Rosa, M. Culebras (Barcelona, Spain). Genotype and progressive lung damage in adult cystic fibrosis patients. Eur Respir J 2003; 22: Suppl. 45, 3144

Member's Comments

No comment yet.

Related content which might interest you: Microcirculation alterations in adult patients with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 262s Year: 2006 The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Factors affecting lung function in adult cystic fibrosis patients after lung transplantation. Source: International Congress 2018 – Evolving approaches to differential diagnosis Year: 2018 Bacterial infection and lung function in patients with cystic fibrosis Source: Eur Respir J 2005; 26: Suppl. 49, 615s Year: 2005 The ageing cystic fibrosis patient Source: International Congress 2018 – PG18 Cystic fibrosis: management in adult patients Year: 2018 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 The lung microbiome in chronic suppurative lung disease: cystic fibrosis and non-cystic fibrosis bronchiectasis Source: Eur Respir Monogr 2019; 83: 158-172 Year: 2019 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 How much genotype influences cystic fibrosis associated liver disease? Source: Eur Respir J 2006; 28: Suppl. 50, 717s Year: 2006 Autopsy findings in 42 consecutive patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2008; 32: 170-174 Year: 2008 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Prevalence of acute liver dysfunction and chronic liver disease in an Irish adult cystic fibrosis population Source: Annual Congress 2010 - New aspects of cystic fibrosis Year: 2010 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Prevalence of renal impairment in an adult cystic fibrosis (CF) centre Source: Eur Respir J 2005; 26: Suppl. 49, 622s Year: 2005